The Cure from CRISPR Classroom

The Cure from CRISPR Classroom

A weekly newsletter by Dr. Kris that demystifies complex medical technologies & connects you with relevant clinical trials based on your requests.

Connect

Archive

New Gene Therapy for Duchenne’s Approved

New Gene Therapy for Duchenne’s Approved

Plus: Myasthenia Gravis: New Drug Approved

Kris Tatiossian, PhD
Kris Tatiossian, PhD
Hidradenitis SuppurativaHidradenitis Suppurativa
+3+3
First Drug Ever for Friedrich’s Ataxia Approved

First Drug Ever for Friedrich’s Ataxia Approved

Plus: Promising New Treatment for Hidradenitis Suppurativa

Kris Tatiossian, PhD
Kris Tatiossian, PhD
cancercancer
+3+3
CRISPR Clinical Trials Ramp Up

CRISPR Clinical Trials Ramp Up

Plus: Brain Cancer Breakthrough

Kris Tatiossian, PhD
Kris Tatiossian, PhD
hashimotos diseasehashimotos disease
+4+4
Breast Cancer and BRCA1

Breast Cancer and BRCA1

Plus: Hashimoto’s: From Tobacco to Treatment

Kris Tatiossian, PhD
Kris Tatiossian, PhD
wegeners granulomatosiswegeners granulomatosis
+2+2
Paraplegic man walks again with brain-spine bridge

Paraplegic man walks again with brain-spine bridge

Plus: Atrial Fibrillation, Blood Clots, and Factor XI

Kris Tatiossian, PhD
Kris Tatiossian, PhD
prostate cancerprostate cancer
+4+4
Targeted Radiation to Fight Prostate Cancer

Targeted Radiation to Fight Prostate Cancer

Plus: Slowing Parkinson's Progression

Kris Tatiossian, PhD
Kris Tatiossian, PhD
cancercancer
+4+4
New Antibody Therapy for Head & Neck Cancer

New Antibody Therapy for Head & Neck Cancer

Plus: RNA Combats Polycystic Kidney Disease

Kris Tatiossian, PhD
Kris Tatiossian, PhD
lung cancerlung cancer
+4+4
Aerosolized Gene Therapy for Cystic Fibrosis

Aerosolized Gene Therapy for Cystic Fibrosis

Plus: Natural Killer Cells Target Lung Cancer

Kris Tatiossian, PhD
Kris Tatiossian, PhD
thyroid eye diseasethyroid eye disease
+4+4
Targeted Cell Therapy for Pancreatic Cancer

Targeted Cell Therapy for Pancreatic Cancer

Plus: Immunotherapy Delivers Promising Results for Thyroid Eye Disease

Kris Tatiossian, PhD
Kris Tatiossian, PhD
dystrophic epidermolysis bullosadystrophic epidermolysis bullosa
+3+3
First Gene Therapy Applied Topically Delivers Results for DEB

First Gene Therapy Applied Topically Delivers Results for DEB

Plus: Innovative Stargardt Gene Therapy Emerges

Kris Tatiossian, PhD
Kris Tatiossian, PhD
medulloblastomamedulloblastoma
+5+5
Myotic Dystrophy Treatment Breakthrough

Myotic Dystrophy Treatment Breakthrough

PLUS: Mysteries Surround Ehlers-Danlos Syndrome

Kris Tatiossian, PhD
Kris Tatiossian, PhD
sickle cell diseasesickle cell disease
+3+3
First CRISPR Treatment Poised for Historic Approval

First CRISPR Treatment Poised for Historic Approval

PLUS: Complexity Challenges Progress in Autism

Kris Tatiossian, PhD
Kris Tatiossian, PhD
FirstBack
12
Next Last